Wells Fargo Downgrades Inspire Medical Systems to Equal-Weight, Announces $187 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Larry Biegelsen downgraded Inspire Medical Systems (INSP) from Overweight to Equal-Weight and set a price target of $187.
December 13, 2023 | 12:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Inspire Medical Systems was downgraded by Wells Fargo from Overweight to Equal-Weight with a new price target of $187.
The downgrade from Overweight to Equal-Weight by a major financial institution like Wells Fargo suggests a neutral outlook on the stock, indicating that the stock's performance is expected to be in line with the market or sector average. The price target of $187 provides a reference point for investors, but the neutral rating implies that significant upside or downside is not anticipated in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100